May 6, 2009 - GE Chairman and CEO Jeff Immelt will hold a press conference at 10 a.m. Thursday, May 7, in Washington, D.C., at the Newseum, 555 Pennsylvania Ave., N.W. , to unveil GE’s new global business strategy for delivering better health care to more people at a lower cost.

May 6, 2009 - Medtronic Inc. today said the FDA approval and availability of the Attain Ability left?heart lead (Model 4196) for use with cardiac resynchronization therapy (CRT) devices for heart failure patients.

May 6, 2009 - University of Utah Health Care this week celebrated the opening of the first integrated electrophysiology (EP) MRI laboratory in North America.

May 6, 2009 - Physicians should review a patient's CT imaging history and cumulative radiation dose when considering whether to perform another CT exam, according to researchers at Brigham and Women's Hospital, Boston, MA, and Washington University School of Medicine, St. Louis, MO.

May 5, 2009 - The Healthcare Information and Management Systems Society (HIMSS) reported that the final registration figures for the 2009 Annual Healthcare Information and Management Systems Society Conference & Exhibition tallied 27,429 total registrants.

The breakdown of the registrants was as follows:
- 6 percent decrease from the 29,177 at HIMSS08

It’s official. Diagnostic & Invasive Cardiology is now owned by Scranton Gillette Communications, a progressive, privately held trade publishing company based in Arlington Heights, Ill. Scranton Gillette has a rich history of building strong brands in the industries it serves, and we are excited to join its experienced team of professionals.

May 5, 2009 - Spectranetics Corp. today released initial data from the four-year, retrospective LExICon (Lead Extraction in Contemporary Settings) study demonstrating the safety and efficacy of laser assisted lead removal using the Spectranetics Laser Sheath (SLS II).

May 5, 2009 - The Society of Cardiovascular Angiography and Interventions (SCAI) will highlight the Cardiac Dimensions Inc. AMADEUS study during its 32nd annual scientific sessions in Las Vegas, Nev., later this week.

May 5, 2009 - ITGI Medical Ltd. Said last week the FDA granted HUD (humanitarian use device) designation to Over and Under and Aneugraft pericardium covered stents for treatment of perforations and dissections of native coronary arteries and saphenous vein grafts.

HUD is the first step towards obtaining market approval from the FDA, the company said.


In an effort to lower the radiation doses patients receive from CT scans, Unilabs Röntgen Majorstuen in Oslo, Norway, installed dose-lowering enhancement software on a trial basis between May and November 2008. In selected cases of thoracic CT, the hospital was able to reduce up to 70 percent of the dose as compared to full-dose examinations.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now